Exxentia

Exxentia was a Spanish biotechnology company specializing in the research, development, and manufacture of natural plant extracts and active ingredients for the pharmaceutical, nutraceutical, and cosmetic industries. The company focused on high-quality botanical extracts with standardized active components, serving global markets with products for cardiovascular health, menopause management, and cognitive function. In 2011, Exxentia was acquired by Frutarom Industries, a move that significantly expanded Frutarom's presence in the natural extracts and functional foods sectors. Following Frutarom's subsequent acquisition by IFF in 2018, Exxentia's operations and product portfolio have been integrated into IFF's Health & Biosciences division. The company was recognized for its expertise in Mediterranean-sourced ingredients, such as olive and grape extracts, as well as its GMP-compliant manufacturing facilities.